Key result
Repeatedly high depression scores linked to ~104% greater risk of adverse HF outcomes.
Why the study?
Although anxiety and depression are linked to adverse outcomes in chronic HF, data on the temporal evolution of these symptoms are scarce.
Are repeatedly measured anxiety and depression symptoms associated with adverse clinical outcomes in patients with chronic heart failure?
Observational (n=362)
Are repeatedly measured anxiety and depression symptoms associated with adverse clinical outcomes in patients with chronic heart failure?
Serial measurements of depression and anxiety symptoms identify chronic HF patients at increased risk of adverse clinical outcomes, suggesting the value of routine screening.
Answers are grounded in this paper and cite their sources.
Serial depression/anxiety scores may stratify risk in chronic HF; hypothesis-generating for screening trials.
BACKGROUND: Although anxiety and depression have been associated with adverse outcomes in chronic heart failure (HF), data on temporal evolution of these symptoms are scarce. We aimed to investigate the association between repeatedly measured depression and anxiety symptoms and clinical outcome in chronic HF patients. METHODS: In this prospective observational study, outpatients with chronic HF were included and followed-up for a maximum of 2.5 years. The hospital anxiety and depression scale (HADS) questionnaire was conducted every six months. The primary endpoint was a composite of HF hospitalization, cardiovascular death, heart transplantation and left ventricular assist device (LVAD) implantation. Cox and joint models were used to investigate the association between the HADS score and the endpoint. RESULTS: A total of 362 patients filled out a median (25th-75th percentile) of 3 [2-4] questionnaires each. Mean ± SD age was 63 ± 13 years, 72% were men. Anxiety scores remained relatively stable leading up to the endpoint, while depression scores increased. Higher baseline depression scores were significantly associated with the endpoint (hazard ratio [HR] 1.68 and 95% confidence interval [CI] 1.19-2.36 per log(score+1), p = 0.003), while higher baseline anxiety scores did not reach statistical significance (HR [95% CI] 1.34 [0.99-1.83], p = 0.061). When repeatedly measured, both higher anxiety (HR [95% CI] 1.57[1.07-2.30], p = 0.022) and depression (HR [95% CI] 2.04 [1.39-3.06], p < 0.001) scores were significantly associated with the endpoint. CONCLUSION: Serial measurements of depression and anxiety symptoms identify chronic HF patients with increased risk of adverse clinical outcomes. Screening for both disorders should be considered in clinical practice.
No takes yet. Share an insight, caveat, or question.
Kamar et al. (2024) conducted an observational in chronic heart failure (n=362). Depression and anxiety symptoms (HADS score) vs. Lower scores was evaluated on Composite of HF hospitalization, cardiovascular death, heart transplantation and left ventricular assist device (LVAD) implantation (HR 2.04, 95% CI 1.39-3.06, p=< 0.001). Repeatedly measured higher depression and anxiety scores were associated with adverse clinical outcomes in HF.
Synapse has enriched 10 related papers. Consider them for comparative context: